2022 Form 10-K Financial Statement

#000164033422001335 Filed on June 27, 2022

View on sec.gov

Income Statement

Concept 2022 2021 Q1 2021
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $140.0M $9.250K $26.71K
YoY Change 524176.6% -11.57% -77.64%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $140.0M $9.250K $26.71K
YoY Change 524117.7% -11.57% -77.63%
Operating Profit -$104.0M -$26.71K
YoY Change 389351.86%
Interest Expense $57.04K -$14.48K $89.83K
YoY Change -36.5% -43.22% -188.83%
% of Operating Profit
Other Income/Expense, Net $57.04K $89.83K
YoY Change -36.5%
Pretax Income -$140.1M -$23.73K -$116.5K
YoY Change 120108.79% -34.01% -47.12%
Income Tax
% Of Pretax Income
Net Earnings -$140.1M -$23.73K -$116.5K
YoY Change 120107.75% -34.01% -47.12%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$12.63M -$490.0K -$2.406M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 2021 Q1 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.85K $16.10K $16.10K
YoY Change 10.87% -10.65%
Accrued Expenses $186.8K $129.8K $129.8K
YoY Change 43.95% 81.5%
Deferred Revenue
YoY Change
Short-Term Debt $320.00 $320.00 $320.00
YoY Change 0.0% 0.0%
Long-Term Debt Due $269.4K $227.7K $227.7K
YoY Change 18.3% 16.09%
Total Short-Term Liabilities $542.0K $451.7K $409.0K
YoY Change 32.52% 30.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $42.68K $42.68K
YoY Change -100.0% 0.0%
Other Long-Term Liabilities $83.58K $83.58K $83.58K
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $83.58K $126.3K $126.3K
YoY Change -33.8% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $542.0K $451.7K $409.0K
Total Long-Term Liabilities $83.58K $126.3K $126.3K
Total Liabilities $625.6K $535.2K $535.2K
YoY Change 16.87% 21.41%
SHAREHOLDERS EQUITY
Retained Earnings -$2.008M
YoY Change
Common Stock $48.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$625.6K -$535.2K -$535.2K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2022 2021 Q1 2021
OPERATING ACTIVITIES
Net Income -$140.1M -$23.73K -$116.5K
YoY Change 120107.75% -34.01% -47.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$32.53K -$6.500K -$28.63K
YoY Change 13.62% 13.84% 1.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $32.53K 6.500K $28.63K
YoY Change 13.62% 13.84% 2.67%
NET CHANGE
Cash From Operating Activities -$32.53K -6.500K -$28.63K
Cash From Investing Activities $0.00 0.000 $0.00
Cash From Financing Activities $32.53K 6.500K $28.63K
Net Change In Cash $0.00 0.000 $0.00
YoY Change -100.0% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$32.53K -$6.500K -$28.63K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 USD
CY2022Q1 us-gaap Commercial Paper
CommercialPaper
6962 USD
CY2021Q1 us-gaap Commercial Paper
CommercialPaper
6962 USD
CY2022Q1 ptco Asset Retirement Obligations Total
AssetRetirementObligationsTotal
83580 USD
CY2021Q1 ptco Asset Retirement Obligations Total
AssetRetirementObligationsTotal
83580 USD
CY2022Q1 us-gaap Liabilities
Liabilities
625548 USD
CY2021Q1 us-gaap Liabilities
Liabilities
535233 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21048440 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48440 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
48 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
141452414 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1472414 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142099010 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2007695 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-625548 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-535233 USD
CY2022 us-gaap Revenues
Revenues
0 USD
CY2021 us-gaap Revenues
Revenues
0 USD
CY2022 us-gaap Salaries And Wages
SalariesAndWages
140000000 USD
CY2021 us-gaap Salaries And Wages
SalariesAndWages
0 USD
CY2022 us-gaap Professional Fees
ProfessionalFees
34275 USD
CY2021 us-gaap Professional Fees
ProfessionalFees
26588 USD
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
125 USD
CY2022 us-gaap Operating Expenses
OperatingExpenses
140034275 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
26713 USD
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-104034275 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-26713 USD
CY2022 us-gaap Interest Expense
InterestExpense
57040 USD
CY2021 us-gaap Interest Expense
InterestExpense
89828 USD
CY2022 us-gaap Other Expenses
OtherExpenses
57040 USD
CY2021 us-gaap Other Expenses
OtherExpenses
89828 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-116541 USD
CY2022 ptco Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-12.63
CY2021 ptco Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-2.41
CY2022 ptco Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
11095016 shares
CY2021 ptco Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
48440 shares
CY2021 ptco Convertible Notes Debt Discount
ConvertibleNotesDebtDiscount
22134 USD
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
140000000 USD
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-140091315 USD
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32533 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28634 USD
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-140091315 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-116541 USD
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
31558 USD
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
140000000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1742 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1921 USD
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
57040 USD
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
58270 USD
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32533 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28634 USD
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
32533 USD
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
6500 USD
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
22134 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2022 ptco Conversion Of Convertible Notes Into Common Shares
ConversionOfConvertibleNotesIntoCommonShares
1000 USD
CY2021 ptco Conversion Of Convertible Notes Into Common Shares
ConversionOfConvertibleNotesIntoCommonShares
0 USD
CY2022 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
0 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
22134 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142099010 USD
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known. The estimates on depreciation were based on the estimated useful lives of the Company’s assets. Any estimates during the period have had an immaterial effect on earnings.</p>
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
421892 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
402716 USD
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.03 pure
CY2022 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1
P20Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.18 pure
CY2022Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
83580 USD
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
421892 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 ptco Reverse Stock Split Description
ReverseStockSplitDescription
common stock on a basis of up to eighty (80) old shares for one (1) new share of common stock.
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21048440 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48440 shares
us-gaap Officers Compensation
OfficersCompensation
105000000 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
67574 USD
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
35041 USD
CY2022Q1 ptco Net Operating Loss Carryforward
NetOperatingLossCarryforward
2009010 USD
CY2021Q1 ptco Net Operating Loss Carryforward
NetOperatingLossCarryforward
1917695 USD
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
402716 USD
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2000000 USD
CY2022 ptco Net Operating Losses Expiration Period Description
NetOperatingLossesExpirationPeriodDescription
expire between 2034 and 2038.
CY2022 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
0.50 pure

Files In Submission

Name View Source Status
0001640334-22-001335-index-headers.html Edgar Link pending
0001640334-22-001335-index.html Edgar Link pending
0001640334-22-001335.txt Edgar Link pending
0001640334-22-001335-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ptco-20220331.xsd Edgar Link pending
ptco-20220331_cal.xml Edgar Link unprocessable
ptco-20220331_def.xml Edgar Link unprocessable
ptco-20220331_lab.xml Edgar Link unprocessable
ptco-20220331_pre.xml Edgar Link unprocessable
ptco_10k.htm Edgar Link pending
ptco_10k_htm.xml Edgar Link completed
ptco_ex311.htm Edgar Link pending
ptco_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending